×
For best experience we recommend to activate Javascript in your browser.
CRABP2 antibody (AA 1-138)
The Rabbit Polyclonal anti-CRABP2 antibody has been validated for WB, IHC, ICC and IP. It is suitable to detect CRABP2 in samples from Human.
Quick Overview for CRABP2 antibody (AA 1-138) (ABIN7614011)
Target
See all CRABP2 Antibodies
CRABP2
(Cellular Retinoic Acid Binding Protein 2 (CRABP2))
Reactivity
All reactivities for CRABP2 antibodies
Human
Host
All hosts for CRABP2 antibodies
Rabbit
Clonality
All clonalities for CRABP2 antibodies
Polyclonal
Conjugate
All conjugates for CRABP2 antibodies
This CRABP2 antibody is un-conjugated
Application
All applications for CRABP2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Product Details anti-CRABP2 Antibody
(hide)
Binding Specificity
All epitopes for CRABP2 antibodies
AA 1-138
Purpose
Cellular Retinoic Acid Binding Protein 2 (CRABP2) Polyclonal Antibody
Sequence
Met1~Glu138
Characteristics
The Cellular Retinoic Acid Binding Protein 2 (CRABP2) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CRABP2
(hide)
Target
CRABP2
(Cellular Retinoic Acid Binding Protein 2 (CRABP2))
Alternative Name
CRABP2
Gene ID
1382
UniProt
P29373
Recently viewed
(hide)
Chat with us , powered by LiveChat